Allurion Technologies (ALURW) Other financing activities (2022 - 2023)
Allurion Technologies posted quarterly Other financing activities of $1.8 million for Q3 2023, up 954.86% year-on-year from $175000.0 in Q3 2022, and up 120.29% on a QoQ basis from $838000.0 in Q2 2023.
Allurion Technologies (ALURW) has 2 years of Other financing activities data on file, last reported at $1.8 million in Q3 2023.
- For the quarter ending Q3 2023, Other financing activities rose 954.86% year-over-year to $1.8 million; the trailing twelve-month figure through Dec 2024 stood at $1.8 million (down 46.49% YoY), and the FY2024 full-year result was $1.4 million, down 60.67% from the prior year.
- Other financing activities for Q3 2023 stood at $1.8 million, up from $838000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.8 million in Q3 2023 and bottomed at $23000.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.85 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 838,000.00 |
| Jun 30, 2023 | 838,000.00 |
| Mar 31, 2023 | 766,000.00 |
| Mar 31, 2023 | 766,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Sep 30, 2022 | 175,000.00 |